Managing Insomnia in Primary Care: Understanding Current and Developing Pharmacological and Nonpharmacological Therapies

— Scroll to the bottom of the page to proceed to activity —

Program Overview:

Insomnia is the most common adult sleep complaint, affecting millions of people in the US, including up to 69% of primary care patients. However, even though it is a common disorder with considerable negative impact, it is underrecognized and many patients remain undiagnosed and untreated.

Nationally known medical experts will discuss sleep physiology and sleep architecture, insomnia, insomnia prevalence and pathology, and the consequences of disrupted slow-wave sleep. Risk factors and the metabolic and cognitive consequences of insomnia will also be addressed while emphasizing current and emerging pharmacologic and nonpharmacologic therapies used in the treatment of insomnia. This educational activity will provide you with case-based examples to illustrate key issues in the management of the patient with insomnia in primary care.

Learning Objectives:

After completing this activity, the participant will be able to

1. Identify the underlying causes and comorbid conditions of insomnia for increased confidence in treatment
2. Assess the current and developing nonpharmacologic and pharmacologic approaches to the management of primary and comorbid insomnia

Accreditation/Designation Statement:

Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience:

This activity is targeted to all physicians and other healthcare professionals who treat patients with insomnia.

Release Date: September 8, 2009
Expiration Date: September 8, 2010

Medium: Online CME

Acknowledgment of Commercial Support:
This activity was developed from the live Best Practices in Primary Care™ program held in Baltimore, Maryland, on April 3, 2009, which was funded by sanofi-aventis US, LLC.

Method of Participation:

To receive CME credit for this activity, you need to review the program (slides and audio). Upon finishing the online CME, complete the post-test and evaluation, and fill out all required personal information. To receive your CME certificate you will need to pass the post-test with 70% accuracy or better.

Post-test and Evaluation:

After completing this activity, click on the Post-test button at the end of the program. If you receive less than 70% on the post-test, you will be returned to the beginning of the activity to review the presentation again. Upon successful completion of the post-test, you will be asked to fill out a program evaluation form and prompted to print your CME certificate.

Statement of Disclosure and Independence:

It is the policy of Primary Care Network, Inc. to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME’s Essential Areas and Policies. In accordance with ACCME requirements, Primary Care Network has Conflict of Interest and Disclosure Policies that are designed to ensure that Primary Care Network sponsored educational activities are fair balanced, independent, evidence‐based and based on scientific rigor.

Primary Care Network’s Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the accompanying presentations at this Primary Care Education program are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity’s commercial supporters.   

Faculty/Planning Committee and Disclosures
David Neubauer, MD
Associate Director, Johns Hopkins Sleep Disorders Center
Assistant Professor, Department of Psychiatry
Johns Hopkins University School of Medicine
Baltimore, MD

Dr. Neubauer is on the advisory board and speaker’s bureau for sanofi-aventis U.S. LLC and Takeda Pharmaceuticals North America, Inc.

Paul P. Doghramji, MD, FAAFP
Attending Physician, Pottstown Memorial Medical Center
Sr Staff Member, Collegeville Family Practice
Medical Director of Health Services, Ursinus College
Collegeville, PA

Dr. Doghramji is on the advisory board for Cephalon. He is also on the speaker’s bureau for Cephalon, Pfizer, Inc., sanofi-aventis U.S. LLC, and Takeda Pharmaceuticals North America, Inc.
           

Daniel N. Duch, PhD
Medical Director, The Chatham Institute
Chatham, NJ

Dr. Duch has no financial relationships to disclose.

Review Committee Disclosure
In accordance with PCN policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias.  The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.

Unlabeled Use Declaration
During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.